With COVID-19 vaccines on the precipice of mass distribution, news media are on fire as they talk about who will get the vaccine first and how it will be distributed. The one thing they aren’t discussing, however, is the definition of “effective” when it comes to these vaccines.
None of the COVID-19 trials for which we have data are designed to find out whether the vaccine reduces hospitalization rates or deaths. They only look at whether it reduces symptoms if you do get infected.
articles.mercola.com
